| | | | | | | | | | |
|
|
|
|
| Dockets Entered On
November 16, 2005
Table of Contents
|
|
|
|
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| 1999P-5106
|
| Identify Sources of Natural Flavorings
|
|
|
|
|
| 2002N-0273
|
| Animal Proteins Prohibited in Ruminant Feed
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| 2004N-0556
|
| Obstetrical and Gynecological Devices; Designation of Special Control for Condom and Condom with Spermicidal Lubricant
|
|
|
|
|
| 2004P-0223
|
| Whole Grain Descriptive Claims
|
|
|
|
|
| 2005M-0454
|
| P980022/S011 - Guardian RT
|
|
|
|
|
| 2005N-0317
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health Claim
|
|
|
|
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
|
|
| 2005P-0116
|
| To take the following actions with regard to aqueous-based drugs for inhalation that has been compounded by pharmacy operations
|
|
|
|
|
| 2005P-0196
|
| Discontinued Formulation of Pantoprazole Sodium Injection
|
|
|
|
|
| 2005P-0433
|
| Adoption of Harmonization Policy by the U.S. Codex Delegation and US Policy in harmony with DSHEA and 19 U.S.C. 3512
|
|
|
|
|
| 2005P-0463
|
| requesting that the Commissioner of Food and Drugs recommend scheduling of tramadol under the Controlled Substances Act
|
|
|
|
|
| 2005P-0465
|
| Withdraw Draft Regulation on Mercury Amalgam
|
|
|
|
|
| 2005V-0461
|
| Laser Light Show
|
|
|
|
|
| 1995S-0158
|
| Community Disclosure of Institutional Review Boards
|
|
|
|
|
| SUP
45
Attachment
|
| Northfield Laboratories Inc BB IND 10719
|
| Vol #:
|
| 49
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
|
|
| LET
16877
|
| Avon Products, Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16878
|
| Doctor's Best, Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16879
|
| Doctor's Best, Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16880
|
| Origins Nautral Resources, Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16881
|
| Nature's Way Products, Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16882
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16883
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16884
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 152
|
|
| | | | | | | | |
|
|
|
|
| LET
16885
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16886
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16887
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16888
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16889
|
| Amrita Veda
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16890
|
| Enzymatic Therapy
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16891
|
| Harmonic Innerprizes
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16892
|
| Iovate Health Science U.S.A., Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16893
|
| American Healing Technologies,Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16894
|
| American Healing Technologies, Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16895
|
| American Healing Technologies, Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16896
|
| American Healing Technologies, Inc.
|
| Vol #:
|
| 152
|
|
|
|
|
| LET
16897
|
| Enzymatic Therapy
|
| Vol #:
|
| 152
|
|
|
|
|
| 1999P-5106
|
| Identify Sources of Natural Flavorings
|
|
|
|
|
| EMC 214
|
| J. Kogen
|
| Vol #:
|
| 3
|
|
|
|
|
| 2002N-0273
|
| Animal Proteins Prohibited in Ruminant Feed
|
|
|
|
|
| C 59
|
| B. Gorman
|
| Vol #:
|
| 4
|
|
|
|
|
| C 60
|
| K. Long
|
| Vol #:
|
| 4
|
|
|
|
|
| C 61
|
| R. Hinthorne
|
| Vol #:
|
| 4
|
|
|
|
|
| C 62
|
| B. Cameron
|
| Vol #:
|
| 4
|
|
|
|
|
| C 63
|
| E. Pelroy
|
| Vol #:
|
| 4
|
|
|
|
|
| C 64
|
| J. Trammell
|
| Vol #:
|
| 4
|
|
|
|
|
| C 65
|
| R. Graham
|
| Vol #:
|
| 4
|
|
|
|
|
| C 66
|
| A. Chekhun
|
| Vol #:
|
| 4
|
|
|
|
|
| C 67
|
| W. Matre
|
| Vol #:
|
| 4
|
|
|
|
|
| C 68
|
| M. Izuchukul
|
| Vol #:
|
| 4
|
|
|
|
|
| C 69
|
| A. Andreoli
|
| Vol #:
|
| 4
|
|
|
|
|
| C 70
|
| C. Williams
|
| Vol #:
|
| 4
|
|
|
|
|
| C 71
|
| J. Harger
|
| Vol #:
|
| 4
|
|
|
|
|
| C 72
|
| P. Meyer
|
| Vol #:
|
| 4
|
|
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
|
|
| EMC 549
|
| Mission Possible International
|
| Vol #:
|
| 8
|
|
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
|
|
| EMC 1158
|
| L. Savageino
|
| Vol #:
|
| 11
|
|
| | | | | | | | |
|
|
|
|
| 2004N-0556
|
| Obstetrical and Gynecological Devices; Designation of Special Control for Condom and Condom with Spermicidal Lubricant
|
|
|
|
|
| EMC 1
|
| S. Girvin
|
| Vol #:
|
| 1
|
|
|
|
|
| 2004P-0223
|
| Whole Grain Descriptive Claims
|
|
|
|
|
| PDN 1
|
| HFC-1 to Patton Boggs LLP
|
| Vol #:
|
| 5
|
|
|
|
|
| 2005M-0454
|
| P980022/S011 - Guardian RT
|
|
|
|
|
| AAV
1
|
| Medtronic MiniMed
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005N-0317
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Record Retention Requirements for the Soy Protein and Risk of Coronary Heart Disease Health Claim
|
|
|
|
|
|
|
|
|
|
|
| EMC 1
|
| B. Sachau
|
| Vol #:
|
| 1
|
|
| |
|
| 2005N-0345
|
| Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
|
|
|
|
|
| C 488
|
| C. Knop
|
| Vol #:
|
| 165
|
|
|
|
|
| C
489
|
| Women's Bar Association of the State of New York (WBASNY)
|
| Vol #:
|
| 165
|
|
|
|
|
| EMC 452
|
| P. Pettee
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 453
|
| D. Lucca
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 454
|
| P. Fleming, MD
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 455
|
| N. Feng
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 456
|
| J. Monaghan
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 457
|
| D. Cohen, MD
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 458
|
| J. Karpinsky
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 459
|
| D. Hamilton
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 460
|
| NARAL Pro-Choice America
|
| Vol #:
|
| 33
|
|
|
|
|
| EMC 461
|
| J. Melenger
|
| Vol #:
|
| 33
|
|
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
|
|
| EMC 66
|
| B. Dole
|
| Vol #:
|
| 4
|
|
|
|
|
| EMC 67
|
| S. Schultz
|
| Vol #:
|
| 4
|
|
|
|
|
| EMC 68
|
| W. Bell
|
| Vol #:
|
| 4
|
|
|
|
|
| EMC 69
|
| A. Cassels
|
| Vol #:
|
| 4
|
|
|
|
|
| EMC 70
|
| T. Wagoner
|
| Vol #:
|
| 4
|
|
|
|
|
| EMC 71
|
| J. Harding
|
| Vol #:
|
| 4
|
|
|
|
|
| EMC 72
|
| R. Beltramini
|
| Vol #:
|
| 4
|
|
|
|
|
| 2005P-0116
|
| To take the following actions with regard to aqueous-based drugs for inhalation that has been compounded by pharmacy operations
|
|
|
|
|
| C 6
|
| L. Smith
|
| Vol #:
|
| 2
|
|
|
|
|
| C 7
|
| M. Reinke
|
| Vol #:
|
| 2
|
|
| | | | | | | | |
|
|
|
|
| 2005P-0196
|
| Discontinued Formulation of Pantoprazole Sodium Injection
|
|
|
|
|
| LET
1
|
| HFD-005 to AAC Consulting Group
|
| Vol #:
|
| 2
|
|
|
|
|
| 2005P-0433
|
| Adoption of Harmonization Policy by the U.S. Codex Delegation and US Policy in harmony with DSHEA and 19 U.S.C. 3512
|
|
|
|
|
| C 2
|
| J. Machado
|
| Vol #:
|
| 1
|
|
| |
|
| 2005P-0463
|
| requesting that the Commissioner of Food and Drugs recommend scheduling of tramadol under the Controlled Substances Act
|
|
|
|
|
| ACK
1
|
| HFA-305 to Rosei Rocha-Judd
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
Attachment
|
| Rosei Rocha-Judd
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005P-0465
|
| Withdraw Draft Regulation on Mercury Amalgam
|
|
|
|
|
| ACK
1
|
| HFA-305 to Consumers for Dental Choice
|
| Vol #:
|
| 1
|
|
|
|
|
| CP
1
|
| Consumers for Dental Choice
|
| Vol #:
|
| 1
|
|
|
|
|
| 2005V-0461
|
| Laser Light Show
|
|
|
|
|
| ACK
1
|
| HFA-305 to New Orleans City Park Inprovement Association
|
| Vol #:
|
| 1
|
|
|
|
|
| VAR
1
|
| New Orleans City Park Inprovement Association
|
| Vol #:
|
| 1
|
|
